Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Alupent Syrup (orciprenaline sulphate) - Important Safety Information from Boehringer Ingelheim

12 November 2010

Important safety information communication from Boehringer Ingelheim on the discontinuation of Alupent® Syrup (orciprenaline sulphate) September 2010.

Important Safety Information - Alupent Syrup (orciprenaline sulphate)

Date Printed: 23 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971